Does Carboxy-hemoglobin Serve as a Stress-induced Inflammatory Marker Reflecting Surgical Insults?
スポンサーリンク
概要
- 論文の詳細を見る
Endogenous carbon monoxide (CO) production has been recently observed to be an index of the inflammatory response, reflecting various insults in critically ill patients. Major surgery is supposed to modulate the production of CO by transcriptional regulation of heme oxygenase (HO). CO is easy to measure as carboxyhemoglobin (CO-Hb) by spectrophotometry; however, whether CO-Hb can be used as an index reflecting surgical insults is unknown. We investigated changes in CO generation during coronary artery bypass graft by measuring CO-Hb concentrations and the expression of HO in circulating blood as well as the expressions of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). The expression ratios of heme oxygenase-1 (HO-1), TNF-α, and IL-1β significantly increased after surgery, and these values correlated significantly with one another. CO-Hb concentrations significantly increased after surgery; however, many of those values during artificial ventilation with high inspired oxygen fraction were within normal limits. Furthermore, changes in CO-Hb concentrations were small when preoperative values were high. On the whole, CO-Hb concentrations significantly but weakly correlated with the expression ratios of the inflammatory mediators. However, they did not correlate in the patients who showed higher preoperative CO-Hb concentrations. These data indicate that CO-Hb concentrations can, in general, reflect the inflammatory response induced by surgical insult; however, CO-Hb measurement may not be a useful form of clinical monitoring because of the limited degree of changes, the variation of baseline values, and the necessity for the management under fixed conditions.
- 日本医科大学医学会の論文
日本医科大学医学会 | 論文
- わが国における腸チフスの疫学的考察--1973年〜1976年届出菌検出例を中心として
- 臨床および実験報告 二絨毛膜双胎妊娠における高年初産の検討
- 救急災害医学の確立と展望[含 略歴 研究業績] (定年退職教授記念講演会講演要旨)
- 臨床のために 関節リウマチの診断と治療
- TNFファミリーの制御による関節リウマチ治療の可能性 (特集 第15回公開「シンポジウム」(アレルギー・膠原病に対する新たな展開))